Merck's (MRK) Hopes Crushed

Print Email

Merck (MRK) had high hopes for its cholesterol drug Cordaptive

According to The Wall Street Journal, things did not work out. The paper reports that the agency issuing a "not approvable" letter for the potential blockbuster.

Douglas A. McIntyre